Although VHL mutations occur much less frequently in renal cancers other than ccRCC, our data support their functional significance when present, a finding that suggests molecular profiling may identify additional RCCs that would respond favorably to treatments targeting HIF signaling. The gene discussed is VHL; the disease is nonpapillary renal cell carcinoma.